Production (Stage)
Qualigen Therapeutics, Inc.
QLGN
$3.42
-$0.10-2.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.17M | 388.20K | 118.70K | 93.20K | 401.80K |
| Total Receivables | 2.01M | 1.30M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.50M | 626.80K | 415.70K | 460.00K | 765.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 450.00K | -- |
| Total Current Assets | 4.68M | 2.31M | 534.40K | 1.00M | 1.17M |
|
|
|||||
| Total Current Assets | 4.68M | 2.31M | 534.40K | 1.00M | 1.17M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.00K | -- | -- | -- | 866.50K |
| Total Assets | 4.69M | 2.31M | 534.40K | 1.00M | 2.03M |
|
|
|||||
| Total Accounts Payable | 1.57M | 1.64M | 1.85M | 1.80M | 2.22M |
| Total Accrued Expenses | 170.20K | 562.90K | 929.10K | 815.20K | 551.20K |
| Short-term Debt | -- | 1.43M | 1.67M | 1.02M | 1.30M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 269.20K | 818.30K | 359.30K | 885.50K | 63.50K |
| Total Other Current Liabilities | 269.20K | 818.30K | 359.30K | 885.50K | 63.50K |
| Total Current Liabilities | 2.01M | 4.45M | 4.81M | 4.52M | 4.14M |
|
|
|||||
| Total Current Liabilities | 2.01M | 4.45M | 4.81M | 4.52M | 4.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 1.43M | 1.67M | 1.02M | 1.30M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.01M | 4.45M | 4.81M | 4.52M | 4.14M |
|
|
|||||
| Common Stock & APIC | 120.02M | 120.06M | 116.13M | 115.31M | 114.70M |
| Retained Earnings | -123.06M | -122.21M | -120.41M | -118.84M | -116.80M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.04M | -2.14M | -4.28M | -3.52M | -2.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 5.72M | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.72M | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.04M | -2.14M | -4.28M | -3.52M | -2.10M |
| Total Preferred Equity | 5.72M | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.68M | -2.14M | -4.28M | -3.52M | -2.10M |
|
|
|||||